In Vivo Effects of Josamycin, Erythromycin, and Placebo Therapy on Nasal Carriage of Staphylococcus aureus

Healthy nasal carriers of Staphylococcus aureus were randomly assigned to one of three treatment regimens: josamycin (1.5 g/day), erythromycin stearate (1.0 g/day), or placebo, each administered orally for 7 days. Quantitative nasal cultures were obtained from each subject at intervals before, durin...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Wilson, Samuel Z., Martin, R. Russell, Putman, Margaret
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1977
Teme:	Pharmacology and Therapeutics
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC351998/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/324389/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.3.407
Oznake:	Označite Brez oznak, prvi označite!